Funder
Shanghai Municipal Health Commission
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference26 articles.
1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
2. Ding C, Li R, Wang P, et al. Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer. Exp Ther Med. 2012;3(5):861–4.
3. Wang X, Li W, Zhang N, et al. Opportunities and challenges of co-targeting epidermal growth factor receptor and autophagy signaling in non-small cell lung cancer. Oncol Lett. 2019;18(1):499–506.
4. Han B, Li K, Wang Q, et al. Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial. JAMA Oncol. 2018;4(11):1569–75.
5. Jain V, Berman AT. Radiation pneumonitis: old problem, new tricks. Cancers (Basel). 2018;10(7):222.